- Clinical Application of Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in Prostate Cancer.
- Inderjeeth AJ, Topp M, Sanij E, Castro E, Sandhu S.
- Cancers (Basel). 2022 Nov 30;14(23):5922. doi: 10.3390/cancers14235922.
- Review
- Free Full Text
- 3D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction.
- Zhang H, Gao H, Gu Y, John A, Wei L, Minhong Huang M, Yu J, Adeosun AA, Weinshilboum RM, Wang L.
- Front Oncol. 2022 Nov 29;12:999302. doi: 10.3389/fonc.2022.999302.
- Germline Variants in DNA Damage Repair Genes and HOXB13 Among Black Patients With Early-Onset Prostate Cancer.
- Trendowski MR, Sample C, Baird T, Sadeghpour A, Moon D, Ruterbusch JJ, Beebe-Dimmer JL, Cooney KA.
- JCO Precis Oncol. 2022 Nov [2022 Nov 29];6:e2200460. doi: 10.1200/PO.22.00460.
- PMID: 36446039
- PubMed abstract
- Source abstract
•• Research news: Genetic Variants Linked to Prostate Cancer in Black Men Identified. (Inside Precision Medicine)